Gene · 2878
Papers2,921
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,921
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A review of nitric oxide and oxidative stress in typical ovulatory women and in the pathogenesis of ovulatory dysfunction in PCOS. | Reprod Biol Endocrinol | 2023 | 37996893 | PubTator, text mining | PubMed |
| A cell abundance analysis based on efficient PAM clustering for a better understanding of the dynamics of endometrial remodelling. | BMC Bioinformatics | 2023 | 37990148 | PubTator, text mining | PubMed |
| MIOX inhibits autophagy to regulate the ROS -driven inhibition of STAT3/c-Myc-mediated epithelial-mesenchymal transition in clear cell renal cell carcinoma. | Redox Biol | 2023 | 37977044 | PubTator, text mining | PubMed |
| Comparison of in-gel and in-solution proteolysis in the proteome profiling of organ perfusion solutions. | Clin Proteomics | 2023 | 37968584 | PubTator, text mining | PubMed |
| Comprehensive single cell aging atlas of mammary tissues reveals shared epigenomic and transcriptomic signatures of aging and cancer. | bioRxiv | 2023 | 37961129 | PubTator, text mining | PubMed |
| Deep neural network for discovering metabolism-related biomarkers for lung adenocarcinoma. | Front Endocrinol (Lausanne) | 2023 | 37955007 | PubTator, text mining | PubMed |
| The correlation between gut microbiome and atrial fibrillation: pathophysiology and therapeutic perspectives. | Mil Med Res | 2023 | 37936201 | PubTator, text mining | PubMed |
| Epigenetic and metabolic reprogramming in inflammatory bowel diseases: diagnostic and prognostic biomarkers in colorectal cancer. | Cancer Cell Int | 2023 | 37936149 | PubTator, text mining | PubMed |
| A molecular classification system for estimating radiotherapy response and anticancer immunity for individual breast cancer patients. | Front Oncol | 2023 | 37927478 | PubTator, text mining | PubMed |
| Circulating miRNAs signature on breast cancer: the MCC-Spain project. | Eur J Med Res | 2023 | 37925534 | PubTator, text mining | PubMed |
| Prediagnostic selenium status, selenoprotein gene variants and association with breast cancer risk in a European cohort study. | Free Radic Biol Med | 2023 | 37923090 | PubTator, text mining | PubMed |
| The analysis of HPV integration sites based on nanopore sequencing and the profiling changes along the course of photodynamic therapy. | BMC Cancer | 2023 | 37914994 | PubTator, text mining | PubMed |
| Comprehensive multi-omics analysis of tryptophan metabolism-related gene expression signature to predict prognosis in gastric cancer. | Front Pharmacol | 2023 | 37908977 | PubTator, text mining | PubMed |
| Evaluating the protective effect of metformin against diclofenac-induced oxidative stress and hepatic damage: In vitro and in vivo studies. | Biochem Biophys Res Commun | 2023 | 37907013 | PubTator, text mining | PubMed |
In Vitro Antioxidant and Inhibitory Study of Picrorhiza kurroa (Kutki), Syzygium aromaticum (Loung), Lawsonia inermis (Henna), Rheum emodi (Revand Chini), Curcuma longa (Haldi) Against Lipid Per-Oxidation in Mice Brain and Liver. | Dose Response | 2023 | 37900620 | PubTator, text mining | PubMed |
| RSL3 Inhibits Porcine Epidemic Diarrhea Virus Replication by Activating Ferroptosis. | Viruses | 2023 | 37896857 | PubTator, text mining | PubMed |
| "Alphabet" Selenoproteins: Implications in Pathology. | Int J Mol Sci | 2023 | 37895024 | PubTator, text mining | PubMed |
| The Crosstalk between Mesenchymal Stromal/Stem Cells and Hepatocytes in Homeostasis and under Stress. | Int J Mol Sci | 2023 | 37894893 | PubTator, text mining | PubMed |
| Hsa-miR-665 Is a Promising Biomarker in Cancer Prognosis. | Cancers (Basel) | 2023 | 37894282 | PubTator, text mining | PubMed |
| Hypoxia-Induced Changes in L-Cysteine Metabolism and Antioxidative Processes in Melanoma Cells. | Biomolecules | 2023 | 37892173 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2878/papers?page=15